6 Oct 2025
India’s healthcare sector is experiencing remarkable and sustained growth, fuelled by demographic shifts, changing disease patterns, progressive policy reforms, and rapid technological advancements. Sector comprises pharmaceuticals, healthcare services (including hospitals and diagnostics), and medical equipment, each playing a crucial role in delivering quality care across the country.
Market Expansion and Financial Significance
India’s domestic healthcare industry is witnessing robust growth across key segments. Healthcare delivery, the largest segment, grew from ₹3.9 lakh crore in Fiscal 2019 to ₹6.3 lakh crore in Fiscal 2024 and is projected to reach ₹9.4–9.8 lakh crore by FY28P. Pharmaceutical retail expanded from ₹1.7 lakh crore in Fiscal 2019 to ₹2.6 lakh crore in Fiscal 2024, while diagnostics and medical devices grew at a CAGR of 7% and 13% respectively, each reaching ~₹90,000 crore in Fiscal 2024. This growth is driven by an aging population, rising lifestyle diseases, increased health awareness, digital adoption (telemedicine, e-pharmacies), and a growing middle class. India is also emerging as a global hub for medical tourism, clinical trials, and pharmaceutical manufacturing.
(Source: Park Hospital DRHP, As per latest data available)
Demographics and Infrastructure Challenges
India’s healthcare system is witnessing ever increasing demand as the population ages and lifestyle diseases become more common, now responsible for most deaths. As more people grow older and join the middle class, demand for healthcare is rising sharply. However, the country continues to face shortages in hospital beds, doctors, and nurses compared to global recommendations. These gaps underscore the urgent need for greater investment in healthcare infrastructure and workforce development to meet the growing needs of its people.
Evolving Landscape of Indian Hospitals and Diagnostics
India’s hospital and diagnostics sector is undergoing significant transformation, with private hospitals rapidly expanding bed capacity, especially in Tier 2 and Tier 3 cities. Occupancy rates have remained robust across leading hospitals, even as average length of stay has reduced, indicating operational efficiency and strong demand. Financial metrics such as Average Revenue Per Occupied Bed (ARPOB) and EBITDA per bed have improved, driven by higher patient revenues and better cost management. Brownfield expansions (upgrading existing facilities) tend to deliver higher returns on capital compared to greenfield projects (new builds). The diagnostics industry has more than doubled since FY17, but India still lags global peers in tests per capita and radiology penetration. The market is shifting from standalone labs to organized chains, with increased penetration in Tier 2–4 cities and a rising share of wellness and preventive testing. Value-added services like home sample collection are supporting growth, while competition from online players is easing, leading to sector consolidation and a focus on profitability. Revenue per patient is consistently rising, and sector valuations have moderated, offering investment opportunities.
Source : Elara Securities, KIE India Health Care Services Report, Philip Capital | As per latest data available
Technology, Innovation, and Digital Health
Technology and innovation are reshaping the healthcare landscape. Digital health solutions such as telemedicine, AI-powered diagnostics, and remote monitoring are transforming care delivery. Among these developments, telemedicine is playing a growing role in extending access to consultations, diagnostics, and follow-ups, particularly in rural and underserved areas. By reducing travel time and costs, and connecting patients with specialists, it is helping make healthcare more accessible and convenient.
Looking Ahead: Opportunities for India’s Healthcare Sector
With robust policy support and rising investments, India’s healthcare sector is on the brink of transformation. Increased government funding, state-led innovation programs, and incentives for domestic manufacturing are laying the foundation for a more resilient and advanced healthcare ecosystem. As technology and talent development accelerate, there are vast opportunities for expanding access, improving quality, and fostering innovation from AI-driven diagnostics to affordable medical devices and digital health solutions.
Addressing persistent challenges like infrastructure gaps and urban-rural disparities will be key. However, with continued commitment from policymakers, industry leaders, and innovators, India is well-positioned to unlock new growth avenues, deliver better health outcomes, and emerge as a global leader in healthcare innovation and delivery.
The stocks/sectors mentioned do not constitute any recommendation and Kotak Mahindra Mutual Fund may or may not have any future position in these sectors/stocks. Use of the company brand names does not imply any affiliation with or endorsement by them or any of its holding companies, subsidiaries or affiliates and are used for illustrative purpose only.
KMAMC is not guaranteeing/offering/communicating any indicative yield/returns on investments. The stocks/sectors mentioned do not constitute any kind of recommendation and are for information purpose only.
These materials are not intended for distribution to or use by any person in any jurisdiction where such distribution would be contrary to local law or regulation. The distribution of this document in certain jurisdictions may be restricted or totally prohibited and accordingly, persons who come into possession of this document are required to inform themselves about, and to observe, any such restrictions.
Kotak Mahindra Mutual Fund may or may not hold position in the mentioned stock(s)/sector(s).
MUTUAL FUND INVESTMENTS ARE SUBJECT TO MARKET RISKS, READ ALL SCHEME RELATED DOCUMENTS CAREFULLY.
